Who owns ACELRX PHARMACEUTICALS INC?
- Ticker: TLPH
- CUSIP Number: 00444t209
Tip: Access positions for across all investors
Analyze quarterly positions in Acelrx Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Acelrx Pharmaceuticals stock
Who bought or sold ACELRX PHARMACEUTICALS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| AIGH Capital Management | 4.7M | $5.3M | 5% | Dec 2025 |
|
| Rock Springs Capital Management | 3.6M | $4.1M | 0% | Dec 2025 |
|
| Rosalind Advisors | 3.6M | $4.1M | -18% | Dec 2025 |
|
| Nantahala Capital Management | 3.5M | $4.0M | 0% | Dec 2025 |
|
| Empery Asset Management | 1.3M | $1.5M | 100% | Dec 2025 |
|
| Bleichroeder | 881k | $1.0M | 0% | Dec 2025 |
|
| Caption Management | 800k | $912k | 220% | Dec 2025 |
|
| Vanguard Group | 664k | $757k | 132% | Dec 2025 |
|
| Cantor Fitzgerald, L. P. | 578k | $658k | 100% | Dec 2025 |
|
| Geode Capital Management | 343k | $391k | 107% | Dec 2025 |
|
| Susquehanna International | 280k | $320k | 2426% | Dec 2025 |
|
| Jane Street | 270k | $308k | 100% | Dec 2025 |
|
| Renaissance Technologies | 257k | $293k | 413% | Dec 2025 |
|
| Dauntless Investment Group | 100k | $89k | 100% | Sep 2025 |
|
| BlackRock | 92k | $104k | 0% | Dec 2025 |
|
| Simplex Trading | 86k | $98k | 6893% | Dec 2025 |
|
| Values First Advisors | 81k | $93k | -17% | Dec 2025 |
|
| Mariner Wealth Advisors | 58k | $66k | 132% | Dec 2025 |
|
| Group One Trading | 57k | $65k | 88% | Dec 2025 |
|
| Northern Trust | 53k | $60k | 383% | Dec 2025 |
|
| State Street Corporation | 22k | $25k | 0% | Dec 2025 |
|
| GSA Capital Partners | 21k | $24k | 100% | Dec 2025 |
|
| Citadel Advisors | 15k | $14k | 100% | Sep 2025 |
|
| Onyx Bridge Wealth Group | 12k | $13k | 0% | Dec 2025 |
|
| UBS Group | 6.8k | $7.7k | -75% | Dec 2025 |
|
| MAI Wealth Advisors | 3.3k | $3.8k | 0% | Dec 2025 |
|
| Tower Research Capital | 2.8k | $3.2k | -55% | Dec 2025 |
|
| Wells Fargo & Company | 983.00 | $1.1k | 104% | Dec 2025 |
|
| SBI Securities | 253.00 | $226.004900 | 0% | Sep 2025 |
|
| Silicon Valley Capital Partners | 137.00 | $156.001900 | 0% | Dec 2025 |
|
| Bnp Paribas Arbitrage, Snc | 136.00 | $154.999200 | 0% | Dec 2025 |
|
| SRS Capital Advisors | 81.00 | $91.999800 | 100% | Dec 2025 |
|
| Global Retirement Partners | 23.00 | $25.999200 | -68% | Dec 2025 |
|
| Dogwood Wealth Management | 10.00 | $11.000000 | 0% | Dec 2025 |
|
Who sold out of Acelrx Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Virtu Financial | Sep 2025 | 33k | $29k |
| PFG Investments | Sep 2025 | 10k | $8.9k |
| Sterling Capital Management | Sep 2025 | 2.0k | $1.8k |
| Goss Wealth Management | Sep 2025 | 500.00 | $447.000000 |
| Raymond James Financial | Jun 2025 | 145.00 | $67.004500 |
| Advisor Group Holdings | Sep 2025 | 26.00 | $14.001000 |